日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MATWIN: bridging the gap between academic research and industry

MATWIN:弥合学术研究与产业之间的差距

Reiffers, Josy; Robert, Lucia

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

在接受伊马替尼一线治疗的慢性粒细胞白血病患者中,获得更深层次的分子学缓解与更好的临床疗效相关。

Etienne, Gabriel; Dulucq, Stéphanie; Nicolini, Franck-Emmanuel; Morisset, Stéphane; Fort, Marie-Pierre; Schmitt, Anna; Etienne, Madeleine; Hayette, Sandrine; Lippert, Eric; Bureau, Caroline; Tigaud, Isabelle; Adiko, Didier; Marit, Gérald; Reiffers, Josy; Mahon, François-Xavier

Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells

p62在急性髓系白血病细胞粒细胞分化过程中的促生存作用

Ségal-Bendirdjian, Evelyne; Tschan, Mario P; Reiffers, Josy; Djavaheri-Mergny, Mojgan

ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells.

ATRA诱导的Beclin 1上调延长了分化的急性早幼粒细胞白血病细胞的寿命

Trocoli Aurore, Mathieu Julie, Priault Muriel, Reiffers Josy, Souquère Sylvie, Pierron Gérard, Besançon Françoise, Djavaheri-Mergny Mojgan

α-defensin 1-3 and α-defensin 4 as predictive markers of imatinib resistance and relapse in CML patients

α-防御素1-3和α-防御素4作为慢性粒细胞白血病患者伊马替尼耐药和复发的预测标志物

Etienne, Gabriel; Dupouy, Maryse; Costaglioli, Patricia; Chollet, Claudine; Lagarde, Valérie; Pasquet, Jean-Max; Reiffers, Josy; Garbay, Bertrand; Mahon, François-Xavier; Turcq, Béatrice